Clinical trial
Open-Label Study of ARD-0403 in Testosterone Deficient Men
NCT00448955 · Ardana Bioscience Ltd, Industry · Completed
Key facts
| NCT number | NCT00448955 |
|---|---|
| Title | Open-Label Study of ARD-0403 in Testosterone Deficient Men |
| Official title | A Phase III Open-Label Study of the Efficacy and Safety of ARD-0403, a Testosterone Cream, in Testosterone Deficient Men |
| Lead sponsor | Ardana Bioscience Ltd, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypogonadism |
| Intervention type | Drug |
| Interventions | ARD-0403 |
| Enrollment | 150 |
| Start date | May 1, 2007 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Mar 19, 2007 |
| Last update posted | Apr 18, 2008 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: